LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. grew its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 43.7% in the third quarter, HoldingsChannel reports. The institutional investor owned 367,935 shares of the company’s stock after acquiring an additional 111,894 shares during the period. Landscape Capital Management L.L.C.’s holdings in LifeStance Health Group were worth $2,576,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Bessemer Group Inc. grew its position in LifeStance Health Group by 43.4% in the 1st quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock valued at $56,000 after acquiring an additional 2,768 shares in the last quarter. Park Edge Advisors LLC acquired a new position in shares of LifeStance Health Group in the third quarter valued at approximately $73,000. CIBC Asset Management Inc purchased a new stake in LifeStance Health Group during the 2nd quarter worth approximately $53,000. Algert Global LLC purchased a new stake in LifeStance Health Group during the 2nd quarter worth approximately $57,000. Finally, Victory Capital Management Inc. lifted its holdings in LifeStance Health Group by 27.0% during the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after buying an additional 3,063 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Trading Up 1.2 %

Shares of NASDAQ:LFST opened at $7.31 on Friday. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $9.20. The company’s 50 day moving average is $7.01 and its two-hundred day moving average is $6.27. The company has a market cap of $2.80 billion, a PE ratio of -28.12 and a beta of 1.24. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The business had revenue of $312.70 million during the quarter, compared to analysts’ expectations of $302.25 million. During the same period in the prior year, the firm posted ($0.17) EPS. The business’s quarterly revenue was up 18.9% compared to the same quarter last year. Equities analysts predict that LifeStance Health Group, Inc. will post -0.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

LFST has been the subject of several research reports. Barclays boosted their price target on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. UBS Group cut their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.